Literature DB >> 6334239

Epithelial cells expressing aberrant MHC class II determinants can present antigen to cloned human T cells.

M Londei, J R Lamb, G F Bottazzo, M Feldmann.   

Abstract

The first step in the induction of immune responses, whether humoral or cell mediated, requires the interaction between antigen-presenting cells and T lymphocytes restricted at the major histocompatibility complex (MHC). These cells invariably express MHC class II molecules (HLA-D region in man and Ia in mouse) which are recognized by T cells of the helper/inducer subset in association with antigen fragments. Interestingly, in certain pathological conditions, for example in autoimmune diseases such as thyroiditis and diabetic insulitis, class II molecules may be expressed on epithelial cells that normally do not express them. We speculated that these cells may be able to present their surface autoantigens to T cells, and that this process may be crucial to the induction and maintenance of autoimmunity. A critical test of this hypothesis would be to determine whether epithelial cells bearing MHC class II molecules (class II+ cells) can present antigen to T cells. We report here that class II+ thyroid follicular epithelial cells (thyrocytes) can indeed present viral peptide antigens to cloned human T cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6334239     DOI: 10.1038/312639a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  115 in total

Review 1.  Evaluation of alveolitis by studies of lung biopsies.

Authors:  P L Haslam
Journal:  Lung       Date:  1990       Impact factor: 2.584

Review 2.  Target organ defects in thyroid autoimmune disease.

Authors:  R S Sundick
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

3.  Enhancement of thyrocyte HLA class II expression by thyroid stimulating hormone.

Authors:  I Todd; R Pujol-Borrell; L J Hammond; J M McNally; M Feldmann; G F Bottazzo
Journal:  Clin Exp Immunol       Date:  1987-09       Impact factor: 4.330

4.  Human cervical epithelial cells that express HLA-DR associated with viral infection and activated mononuclear cell infiltrate.

Authors:  S Fais; F Delle Fratte; F Mancini; V Cioni; M Guadagno; G Vetrano; F Pallone
Journal:  J Clin Pathol       Date:  1991-04       Impact factor: 3.411

5.  Synergy in antigen presentation by thyroid epithelial cells and monocytes from patients with Graves' disease.

Authors:  K Eguchi; T Otsubo; Y Kawabe; C Shimomura; Y Ueki; H Nakao; H Tezuka; M Matsunaga; T Fukuda; N Ishikawa
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

6.  Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity.

Authors:  Kaoru Saegusa; Naozumi Ishimaru; Kumiko Yanagi; Rieko Arakaki; Kouichi Ogawa; Ichiro Saito; Nobuhiko Katunuma; Yoshio Hayashi
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

7.  Identification of thyroid stimulating hormone receptor-specific T cells in Graves' disease thyroid using autoantigen-transfected Epstein-Barr virus-transformed B cell lines.

Authors:  R J Mullins; S B Cohen; L M Webb; Y Chernajovsky; C M Dayan; M Londei; M Feldmann
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

8.  Increased epithelial expression of HLA-DQ and HLA-DP molecules in salivary glands from patients with Sjögren's syndrome compared with obstructive sialadenitis.

Authors:  P S Thrane; T S Halstensen; H R Haanaes; P Brandtzaeg
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

9.  Increased limb involvement in murine collagen-induced arthritis following treatment with anti-interferon-gamma.

Authors:  R O Williams; D G Williams; M Feldmann; R N Maini
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

10.  MHC Class II Antigen Presentation by the Intestinal Epithelium Initiates Graft-versus-Host Disease and Is Influenced by the Microbiota.

Authors:  Motoko Koyama; Pamela Mukhopadhyay; Iona S Schuster; Andrea S Henden; Jan Hülsdünker; Antiopi Varelias; Marie Vetizou; Rachel D Kuns; Renee J Robb; Ping Zhang; Bruce R Blazar; Ranjeny Thomas; Jakob Begun; Nicola Waddell; Giorgio Trinchieri; Robert Zeiser; Andrew D Clouston; Mariapia A Degli-Esposti; Geoffrey R Hill
Journal:  Immunity       Date:  2019-09-18       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.